Tsuneyasu Kaisho

12PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Chemical and thermal processes in energy and combustionPredictive and prognostic markersAllergyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 08, 2026
Autologous Glypican-3-Targeted, Armored CAR T Cells in Patients with Advanced Solid Tumors: A Phase 1 Dose-Escalation Study of TAK-102.

|Jun 15, 2026
Short-term manufacturing of IL-7/CCL19-expressing CAR-T cells enhances and prolongs therapeutic effects in solid tumor models.

|May 26, 2026
Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC.

|Feb 07, 2026
CAR-T cells co-expressing IL-7 and CCL19 promote epitope spreading to enhance antitumor immunity.

Keishi Adachi, Yukimi Sakoda, Tsuneyasu Kaisho

|Feb 02, 2026
Analysis of Peripheral T Cell Profiling and Plasma Proteomics in Advanced NSCLC Patients Treated With Atezolizumab.

Atsuto Mouri, Hiroshi Kagamu, Koji Tamada

|Sep 06, 2024
Therapeutic Efficacy of IL7/CCL19-Expressing CAR-T Cells in Intractable Solid Tumor Models of Glioblastoma and Pancreatic Cancer.

Keisuke Ohta, Yukimi Sakoda, Keishi Adachi

Pageof 2

Frequent Collaborators

6 joint publications

Keishi Adachi

3 joint publications

Yukimi Sakoda

2 joint publications

Tetsuya Mitsudomi

2 joint publications

Akihiko Gemma